モラルとサイエンスの共存をめざして

InCROM Group Overview

Overview

Year of Establishment 1975
President Jinjiro Kanada
Headquarters Nishiwaki, Japan
Office Locations InCROM JAPAN (Osaka, Japan)
InCROM JAPAN (Tokyo, Japan)
InCROM CHINA (Shanghai, China)
InCROM CHINA (Beijing, China)
InCROM CHINA (Chengdu, China)
InCROM CHINA (Guangzhou, China)
InCROM HONG KONG (Hong Kong, China)
InCROM CRO(Osaka, Japan)

History

June 1983 Rabiton Institute Inc. established in Osaka
June 1983 OPHA Clinic (Phase I) established in Osaka
Aug 1983 InCROM JAPAN (previously known as OCROM Inc.) established in Osaka
July 1999 InCROM JAPAN Tokyo office established
July 1999 OCROM Clinic (Phase II-IV) established in Osaka
Feb 2000 InCROM EUROPE (previously known as EuCROM plc.) established in London
June 2000 ToCROM Clinic (Phase II-IV) established in Tokyo
Sept 2003 InCROM CHINA (previously known as ShanCROM) established in Shanghai
July 2004 Japan-China Clinical Trial Centre of Hypertension (JCCTCH) established in Shanghai
Nov 2005 OPHAC Hospital established in Osaka
Jan 2006 Heishinkai Medical Group established in Osaka
Jan 2006 OCROM Clinic joined Heishinkai Medical Group
April 2006 OPHA Clinic merged into OCROM Clinic
April 2006 OCROM Clinic expanded to become a Phase I-IV facility
July 2006 OPHAC Hospital joined Heishinkai Medical Group
July 2007 InCROM Clinical Research Unit (ICRU; Phase I/II) established in London
Sept 2007 InCROM HONG KONG established
Nov 2007 InCROM CHINA Beijing office established
May 2008 InCROM CHINA Chengdu office established
June 2010 InCROM CHINA Guangzhou office established
Nov 2010 InCROM EUROPE was closed
Dec 2010 Rabiton CRO Operations Department was spun-off to form InCROM CRO Inc.